论文信息 - Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination - 字舞流文

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination

G. Rahav | S. Levi | O. Bairey | A. Polliack | Y. Herishanu | T. Ziv-Baran | A. Braester | O. Benjamini | L. Shvidel | T. Tadmor | N. Dally | G. Itchaki